Search
for
Sort by
Research 31–60 of 1000+
- Drug safety evaluation of exemestane
- Hair loss in the elderly
- Is dehydroepiandrosterone a hormone?
- Researchers Link Early Hair Loss and Prostate Cancer
- Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events
- Recent advances in oxasteroids chemistry
- Clinical perspective on management of key adverse events with sacituzumab govitecan
- Imaging to study solid tumour origin and progression: lessons from research and clinical oncology
- DRUG NEWS
- Abstract SS02-02: Chemoprevention: Poised for Success
- Hormone Blocking Anticancer Drugs
- Tamoxifen for flutamide/finasteride-induced gynecomastia
- High incidence of severe hand–foot syndrome during capecitabine–docetaxel combination chemotherapy
- Evaluating changes in the breast cancer-related quality of life of young women with breast cancer: long-term results from a multicenter prospective cohort
- Trailing the Path to Preventive Oncology
- Ectopic Expression of a Truncated Isoform of Hair Keratin 81 in Breast Cancer Alters Biophysical Characteristics to Promote Metastatic Propensity
- Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in Germany
- Robotic surgical systems in plastic and reconstructive surgery
- Sulfotransferases, sulfatases and formylglycine-generating enzymes: a sulfation fascination
- Giant Morpheaform Basal Cell Carcinoma Mimicking Scarring Alopecia: Exception Prone to Neglect
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- The relationship between keratin 18 and epithelial-derived tumors: as a diagnostic marker, prognostic marker, and its role in tumorigenesis
- Steroid sulfatase inhibitors
- TACRINE
- The Current Status of the Pharmaceutical Potential of Juniperus L. Metabolites
- First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
- Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”
- Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link?
- Efficacy of Scalp Cooling combined with DHL-HisZnNa Lotion in the Prevention of Chemotherapy-Induced Alopecia in Patients with Breast Cancer
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer